Mohamed Al Ibrahim
Infectious Disease · Baltimore, MDNPI 1245334325
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $20 of the $20 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Pfizer. That places this record below the midpoint for infectious disease clinicians in MD, where the typical reported total is $209.
Across 1 payment — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$20
Across 250 payments — averaging $19,682 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2.7M
- Merck$1.8M
- AstraZeneca$213K
- Novartis$126K
What the payments were for
- Gifts$20100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $20 |
How this compares
$20 in reported general payments places this provider in the 25th percentile of 289 infectious disease providers in Maryland.
Other infectious disease in Baltimore
- Robert RedfieldBaltimore$779K
- Luciana BorioBaltimore$671K
- Mark SulkowskiBaltimore$240K
- Jonathan ZenilmanBaltimore$202K
- Robert EdelmanBaltimore$125K
- Kjell WibergBaltimore$113K
- Christine DurandBaltimore$53K
- Myron LevineBaltimore$51K
- Robert BollingerBaltimore$50K
- Richard BergBaltimore$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.